Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-12 to 2025-08-13
Current total value of award: $1367.22
Description: 4569070812!TELMISARTAN-HCTZ 80-12.5 MG TB UD 30S